ALX Oncology Doses First Patient in Phase 1 Trial of ALX1004
ALX Oncology has initiated a Phase 1 trial of ALX2004, an epidermal growth factor receptor (EGFR) antibody-drug conjugate (ADC),...
Capricor Doses First Subjects in Phase 1 Exosome Vaccine Trial
Capricor Therapeutics has initiated a Phase 1 trial of its StealthX™ exosome-based vaccine platform. The trial, funded by the...
Biodexa Initiates Phase 3 Serenta Trial for Familial Adenomatous Polyposis
Biodexa has initiated its pivotal Phase 3 Serenta trial of eRapa in patients with familial adenomatous polyposis (FAP). The...
Ascentage Pharma’s Lisaftoclax Enters Phase III Trial for Myelodysplastic Syndrome
Ascentage Pharma has secured both FDA and EMA clearance for its global Phase 3 GLORA-4 trial evaluating lisaftoclax, a...
Jabez BioSciences Opens Second Site in Oncology Study
Jabez Biosciences has opened a second clinical site for its Phase 1 trial of JBZ-001, a dihydroorotate dehydrogenase (DHODH)...
BioAge Labs Doses First Patient in BGE-102 Phase 1 Trial
BioAge Labs has initiated a Phase 1 trial of BGE-102, an oral NLRP3 inhibitor, in healthy volunteers. Initial single...
Global Clinical Trial Supplies Market to Reach $8.18B by 2030
The global clinical trial supplies market, valued at $5.34 billion in 2025, is projected to reach $8.18 billion by...
Uncommon Olfactory Code in Fruit Fly Brains Revealed
Taiwan’s National Tsing Hua University (NTHU) research team has mapped the hybrid neural network fruit flies use for rapid...
EFX Shows Promising Liver Fibrosis Reduction in Phase 2B HARMONY Trial
96-week data from the HARMONY Phase 2b trial show Akero Therapeutics’ efruxifermin (EFX) yielded a 49% achievement rate for...
Invivyd and FDA Align on Accelerated Approval for COVID-19 Antibody
Invivyd has received FDA guidance on a streamlined Phase 2/3 trial design for VYD2311, its monoclonal antibody (mAb) candidate...